Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. The European Commission closes Tele2 investigation
Mandate

The European Commission closes Tele2 investigation

November 13, 2018 EU, Competition and Regulatory

On 25 April 2017 the European Commission conducted dawnraids at the premises of Tele2 and three other mobile network operators active in Sweden regarding potential infringements of EU competition law.

The Commission has informed Tele2 that the investigation has been closed without any further action. Vinge assisted Tele2 during the investigation.

Vinge’s team consisted of, among others, partners Johan Karlsson and Marcus Glader, economic expert Jakob Jeanrond and associates Johan Wahlbom and Xandra Ståhlberg.
 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026